SCHEMBL21730455

SCHEMBL21730455

CCN1CCC12CCOCC2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24221051 0.78
SCHEMBL17813254 0.76 SOS1 (0.31)
SCHEMBL19120824 0.75 MCHR1 (0.33)
SCHEMBL22142715 0.75 MCHR1 (0.33)
SCHEMBL25044485 0.75
SCHEMBL19069659 0.74 ROCK2 (0.31)
SCHEMBL23063449 0.73 TSHR (0.36)
SCHEMBL17722846 0.71
SCHEMBL22813067 0.71 ALDH1A1 (0.31)
SCHEMBL23570376 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023018648-A1 PHENOL DERIVATIVES FOR USE IN THE MODULATION OF BRM GENENTECH, INC. (US) 2023-02-16 WO disclosed
US-10966987-B2 Therapeutic compounds and uses thereof KALA PHARMACEUTICALS, INC. (US) 2021-04-06 US disclosed
US-20200054644-A1 THERAPEUTIC COMPOUNDS AND USES THEREOF KALA BIO, Inc. 2020-02-20 US disclosed